4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-20-005416
Director sold 345,000 shares at $26.50 ($9,142,500)
- Director acquired 100,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
ZOLTNERS ANDRIS A · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-01-28 | Exercise or conversion : show line 1 in the form | +100,000 | $0.16 | $16,000 | 3,966,016 | D |
| 2020-01-28 | Sale : show line 2 in the form | −345,000 | $26.50 | $9,142,500 | 3,621,016 | D |
| Open-market sales · 345,000 sh · avg $26.50 · $9,142,500 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-01-28 | Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) | −100,000 | 0 | D |
Loading xslF345X03/doc4.xml…